Literature DB >> 8275452

Tetrasomy 8 in acute monoblastic leukemia (AML-M5a) with myelosarcomatosis of the skin.

C Marosi1, M Muhm, A Argyriou-Tirita, H Pehamberger, H Pirc-Danoewinata, K Geissler, G Locker, N Grois, O A Haas.   

Abstract

We report a new case with isolated tetrasomy 8, an 82-year-old female patient in whom multiple disseminated nodular skin infiltrations up to 5 cm in diameter preceded acute monoblastic leukemia (AML-M5a). Despite an initial response to chemotherapy and radiotherapy, the patient died 1 year after diagnosis of relapsed leukemia. To assess the size of the tetrasomic clone, fluorescence in situ hybridization (FISH) analysis with a centromere-specific chromosome 8 probe was performed. Seventy percent of interphase cells showed four signals and 22% showed three signals. Because this trisomic clone was not detected by conventional cytogenetics, tetrasomic cells may have a proliferation advantage in vitro. Whether tetrasomy 8 arises from a simultaneous mitotic nondisjunction of both chromosomes 8 during one cell division or evolves secondarily from trisomy 8 through a second mitotic error is not known. Alternatively, trisomy 8 may originate from tetrasomy 8 by loss of one chromosome 8.

Entities:  

Mesh:

Year:  1993        PMID: 8275452     DOI: 10.1016/0165-4608(93)90201-v

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Myeloid Sarcoma and Acute Myelomonocytic Leukemia in an Adolescent with Tetrasomy 8: Staging with (18)F-FDG PET/CT.

Authors:  William Makis; Rajan Rakheja; Josee Lavoie; Marc Hickeson
Journal:  Nucl Med Mol Imaging       Date:  2012-02-14

2.  A case of acute myeloid leukemia (AML) with an unreported combination of chromosomal abnormalities: gain of isochromosome 5p, tetrasomy 8 and unbalanced translocation der(19)t(17;19)(q23;p13).

Authors:  Christian Paar; Gabriele Herber; Daniela Voskova; Michael Fridrik; Herbert Stekel; Jörg Berg
Journal:  Mol Cytogenet       Date:  2013-09-30       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.